These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2304282)

  • 1. Nuclear DNA content in breast carcinoma with special reference to the parameters of malignant potentiality.
    Suehiro S; Hamada Y; Toi M; Nakamura T; Niimoto M; Hattori T
    Jpn J Surg; 1990 Jan; 20(1):115-8. PubMed ID: 2304282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of estrogen receptor status to DNA ploidy in breast cancer.
    Tsuchiya A; Nihei M; Ando Y; Suzuki S; Kimijima I; Abe R
    Surg Today; 1992; 22(2):105-9. PubMed ID: 1498488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.
    Harvey J; de Klerk N; Berryman I; Sterrett G; Byrne M; Papadimitriou J
    Breast Cancer Res Treat; 1987; 9(2):101-9. PubMed ID: 3304476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
    Pinto AE; André S; Soares J
    J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor.
    Olszewski W; Darzynkiewicz Z; Rosen PP; Schwartz MK; Melamed MR
    Cancer; 1981 Aug; 48(4):980-4. PubMed ID: 7272940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma?
    Keyhani-Rofagha S; O'Toole RV; Farrar WB; Sickle-Santanello B; DeCenzo J; Young D
    Cancer; 1990 Apr; 65(7):1577-82. PubMed ID: 2311069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ploidy level of human breast carcinoma. Relation to histopathologic features and hormone receptor content.
    Jakobsen A; Poulsen HS; Madsen EL; Petersen SE; Hansen HS
    Acta Radiol Oncol; 1984; 23(2-3):103-7. PubMed ID: 6331077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of flow cytometry to clinical factors, hormone receptors, and histopathological grade in stage I and II invasive breast carcinoma.
    Haghbin M; McCue PA; Mansfield CM; Komarnicky LT; Benammar A; Schwartz GF
    Am J Clin Oncol; 1996 Feb; 19(1):54-8. PubMed ID: 8554037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relation of steroid receptors, tumor ploidy, and cell proliferation in various histologic types of breast cancer].
    Zubrikhina GN; Ermilova VD; Kuz'mina ZV; Bassalyk LS
    Arkh Patol; 1989; 51(3):10-6. PubMed ID: 2545183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of DNA index heterogeneity in advanced breast carcinomas. Evidence for DNA ploidy differences between lymphatic and hematogenous metastases.
    Bonsing BA; Beerman H; Kuipers-Dijkshoorn N; Fleuren GJ; Cornelisse CJ
    Cancer; 1993 Jan; 71(2):382-91. PubMed ID: 8422632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
    Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
    Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA ploidy and survival in breast cancer patients.
    Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
    Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA proliferative index as a marker in Iraqi aneuploid mammary carcinoma.
    al-Alwan NA
    East Mediterr Health J; 2000; 6(5-6):1062-72. PubMed ID: 12197329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy in intraductal breast carcinomas.
    Aasmundstad TA; Haugen OA
    Eur J Cancer; 1990; 26(9):956-9. PubMed ID: 2177615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the combined assessment of proliferating cell nuclear antigen immunostaining and nuclear DNA content in invasive human mammary carcinomas.
    Schimmelpenning H; Eriksson ET; Franzén B; Zetterberg A; Auer GU
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(4):273-9. PubMed ID: 7901939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of age on the DNA ploidy levels of breast tumours.
    Taylor IW; Musgrove EA; Friedlander ML; Foo MS; Hedley DW
    Eur J Cancer Clin Oncol; 1983 May; 19(5):623-8. PubMed ID: 6683634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of DNA ploidy patterns in esophageal squamous cell carcinoma. An ultraviolet microspectrophotometric study.
    Minu AR; Endo M; Sunagawa M
    Cancer; 1994 Jul; 74(2):578-85. PubMed ID: 8033036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.
    Yokoe T; Izuo M; Ishida T; Iino Y; Kawai T
    Jpn J Surg; 1990 Sep; 20(5):491-7. PubMed ID: 2243441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.